← FDA Drug Approvals (Drugs@FDA)

HALOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOUGERA PHARMS · Approved 2004-12-16

Drug application

FDA Application #
ANDA076903
Application type
Abbreviated New Drug Application (Generic)
Brand name
HALOBETASOL PROPIONATE
Generic name
Halobetasol Propionate
Active ingredients
HALOBETASOL PROPIONATE
Dosage form
OINTMENT
Route
TOPICAL
Marketing status
Discontinued
Sponsor
FOUGERA PHARMS
First approval
2004-12-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown